Monument Capital Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Monument Capital Management's GILD Position: Q2 2026 in Review
Monument Capital Management reduced its Gilead Sciences (GILD) stake by 56% in Q2 2026, selling an estimated $2.07M and leaving 12,267 shares worth $1.55M. The position accounts for 0.31% of the portfolio, ranked #92.
Monument Capital Management first reported a position in GILD in Q3 2018 and has held it in 17 quarters since. The position peaked at $3.89M in Q1 2026. 1,031 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Monument Capital Management held 12,267 shares of Gilead Sciences worth $1.55M as of Q2 2026.
- Monument Capital Management sold 15,679 Gilead Sciences shares in Q2 2026, an estimated $2.07M.
- Gilead Sciences made up 0.31% of Monument Capital Management's portfolio in Q2 2026, its #92 holding.
- Monument Capital Management first reported a position in Gilead Sciences in Q3 2018 and has held it in 17 quarters since.
- Monument Capital Management's Gilead Sciences position peaked at $3.89M in Q1 2026.
- 1,031 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Monument Capital Management's 13F filing for Q2 2026, filed 22 Jul 2026.